4Dmedical (ASX:4DX)
ASX announcement history & article coverage
Transparent by design.
Announcments by 4Dmedical (ASX:4DX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Becoming a substantial holder
Cleansing Notice
Application for quotation of securities - 4DX
Application for quotation of securities - 4DX
Ceasing to be a substantial holder
Cleansing Notice
Application for quotation of securities - 4DX
Application for quotation of securities - 4DX
Change of Director's Interest Notice LB JL
Cleansing Notice
Application for quotation of securities - 4DX
Application for quotation of securities - 4DX
Proposed issue of securities - 4DX
Proposed issue of securities - 4DX
4DMedical receives TGA approval for CTVQ in Australia
4DMedical secures TGA approval for CT:VQ™ in Australia enabling commercial rollout
Becoming a substantial holder
Becoming a substantial holder
Change of Director's Interest Notice JS
Ceasing to be a substantial holder
Becoming a substantial holder
Change in substantial holding
Application for quotation of securities - 4DX
4DMedical targets US$2.5B PE market entry for CTVQ
4DMedical launches CLEAR program targeting US$3B acute pulmonary embolism market with CT:VQ™
Proposed issue of securities - 4DX
Proposed issue of securities - 4DX
4DMedical creates EU platform via contextflow acquisition
4DMedical acquires contextflow to establish European platform and expand lung health market presence
Application for quotation of securities - 4DX
CTVQ enters US Outpatient Market via SimonMed 170 sites
4DMedical inks 3-year commercial deal with SimonMed Imaging for US outpatient CT:VQ™ deployment
Becoming a substantial holder
Becoming a substantial holder
Ceasing to be a substantial holder
Becoming a substantial holder
Ceasing to be a substantial holder
Major publication validates CTVQ for lung surgery
4DMedical's CT:VQ™ validated in leading respiratory journal, boosts lung surgery outcomes and economics
Application for quotation of securities - 4DX
Becoming a substantial holder
Ceasing to be a substantial holder
Application for quotation of securities - 4DX
Quarterly Activity Report and Appendix 4C
4DMedical accelerates CT:VQ adoption, secures GSK contract, achieves EU and UK regulatory clearances, raises $233m, and joins ASX 200
Becoming a substantial holder
GSK contract, UK clearance for CTVQ, and ASX 200 inclusion
4DMedical secures GSK contract, UK clearance for CT:VQ™, US CAC reimbursement, and ASX 200 inclusion
Cleansing Notice
Application for quotation of securities - 4DX